A drug used to reduce the risk of recurrences in about half of breast cancer patients may also help the other half , as well as people with other types of cancer , researchers said . A new study by Dr. Michael Pollak , an assistant professor of oncology and medicine at McGill University in Montreal , published in the Journal of the National Cancer Institute , found the drug , tamoxifen , apparently reduces levels of a protein that promotes the growth of cancer cells .